Mechanisms of progression of renal damage in lupus nephritis: Pathogenesis of renal scarring

被引:51
作者
Grande, JP
机构
[1] Mayo Clin & Mayo Fdn, Dept Internal Med, Div Nephrol, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Div Anat Pathol, Rochester, MN 55905 USA
关键词
fibrosis; lupus nephritis; progression; reactive oxygen species (ROS); TGF-beta;
D O I
10.1191/096120398678920721
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lupus nephritis results from an acute inflammatory and immunological response to renal immune complex deposition. The acute response is characterized by activation of circulating leukocytes and renal parenchymal cells, triggering the production of pro-inflammatory cytokines and growth factors. In all too many cases, this response is followed by a chronic response, which is characterized by excessive deposition of collagen and other extracellular matrix macromolecules and the development of end-stage renal disease. Mechanisms underlying this chronic response in progressive renal disease are not adequately defined. In this overview, potential roles of reactive oxygen species (ROS) generation and transforming growth factor-beta (TGF-beta) production in the pathogenesis of lupus nephritis are considered. ROS and TGF-beta may be key elements of a pathway leading to persistent and excessive matrix deposition in progressive lupus nephritis. Further studies to define the role of this pathway in lupus nephritis may lead to the development of additional, more specific therapeutic targets to prevent progression of renal disease.
引用
收藏
页码:604 / 610
页数:7
相关论文
共 87 条
[21]   TGF-BETA-1 PRODUCES A PROOXIDANT EFFECT ON BOVINE PULMONARY-ARTERY ENDOTHELIAL-CELLS IN CULTURE [J].
DAS, SK ;
FANBURG, BL .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (04) :L249-L254
[22]  
DUQUE I, 1993, J PHARMACOL EXP THER, V267, P612
[23]  
EDDY AA, 1994, RENAL PATHOLOGY, V1, P162
[24]  
FARBER JL, 1990, LAB INVEST, V62, P670
[25]  
FOSTER MH, 1993, LAB INVEST, V69, P494
[26]   RECOGNITION OF OXIDIZED DNA BASES BY SERA OF PATIENTS WITH INFLAMMATORY DISEASES [J].
FRENKEL, K ;
KARKOSZKA, J ;
KIM, E ;
TAIOLI, E .
FREE RADICAL BIOLOGY AND MEDICINE, 1993, 14 (05) :483-494
[27]  
GRANDE J, 1993, LAB INVEST, V69, P387
[28]   Modulation of collagen gene expression by cytokines: Stimulatory effect of transforming growth factor-beta 1, with divergent effects of epidermal growth factor and tumor necrosis factor-alpha on collagen type I and collagen type IV [J].
Grande, JP ;
Melder, DC ;
Zinsmeister, AR .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1997, 130 (05) :476-486
[29]   Antibodies to DNA [J].
Hahn, BH .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (19) :1359-1368
[30]  
Harpel John G., 1992, Progress in Growth Factor Research, V4, P321, DOI 10.1016/0955-2235(92)90014-9